SG Americas Securities
ODT

SG Americas Securities’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

SG Americas Securities’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,031
Closed -$135K – 3665
2020
Q4 		$135K Buy
+7,031
New +$109K ﹤0.01% 2880
2020
Q3 		– Sell
-7,103
Closed -$301K – 3741
2020
Q2 		$301K Buy
+7,103
New +$230K ﹤0.01% 2519

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

SG Americas Securities's ODT Position: Q1 2021 in Review

SG Americas Securities sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 7,031 shares — an estimated $135K sold.

SG Americas Securities first reported a position in ODT in Q2 2020 and held it in 2 quarters. The position peaked at $301K in Q2 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • SG Americas Securities reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • SG Americas Securities sold 7,031 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $135K.
  • SG Americas Securities first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • SG Americas Securities's Odonate Therapeutics, Inc. Common Stock position peaked at $301K in Q2 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on SG Americas Securities's 13F filing for Q1 2021, filed 13 May 2021.